BioNexus Gene Lab Corp. (BGLC) Revenue 2018–2025
BioNexus Gene Lab Corp. (BGLC) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$7.4MFY2025 · since FY2018: $212,328 → $7.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.4M | -21.9% |
| FY2024 | $9.5M | -2.7% |
| FY2023 | $9.8M | -10.6% |
| FY2022 | $10.9M | -18.2% |
| FY2021 | $13.4M | +17.3% |
| FY2020 | $11.4M | +8872.0% |
| FY2019 | $126,955 | -40.2% |
| FY2018 | $212,328 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BGLC financial trends
BGLC Net incomeBGLC Net marginBGLC Gross profitBGLC Gross marginBGLC Operating incomeBGLC Operating marginBGLC Operating cash flowBGLC Free cash flowBGLC Capital expendituresBGLC Return on equityBGLC Stock buybacksBGLC Dividends paidBGLC Total assetsBGLC Total liabilitiesBGLC Shareholders’ equityBGLC overview →